LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p/VEGFA
- PMID: 37728844
- DOI: 10.1007/s13258-023-01440-3
LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p/VEGFA
Abstract
Background: Long non-coding RNAs (lncRNAs) play a critical role in the development of ovarian cancer (OC).
Objective: The study aimed to determine the role of LncRNA LINC01123 in OC bio-progression, which is upregulated in OC tissues during OC progression.
Methods: Bioinformatics methods, GEPIA, and qRT-PCR were used to reveal the level and correlation of LINC01123, hsa-miR-516b-5p, and VEGFA, in OC cell lines. MTT, EdU, TUNEL, and Transwell assays were performed to assess the bioactivity of OC cell. Target sites of LINC01123 and hsa-miR-516b-5p were predicted using Starbase, and the potential linkage points of VEGFA and hsa-miR-516b-5p were predicted using TargetScan. These sites and linkage points were confirmed by double luciferase reporter assay.
Results: LINC01123 was upregulated in OC cell lines and LINC01123 silencing suppressed the proliferation and metastasis of OC cells, but promoted cell apoptosis. hsa-miR-516b-5p was linked to LINC01123 and. VEGFA was downstream of hsa-miR-516b-5p. Importantly, silencing of hsa-miR-516b-5p reversed the inhibitory impact of si-LINC01123. The result of hsa-miR-516b-5p inhibitor + si-LINC01123 co-transfection were rescued by si-VEGFA.
Conclusion: LINC01123 promotes OC development by dampening miR-516b-5p function, and may be a novel target for treating OC.
Keywords: Hsa-miR-516b-5p; LINC01123; Long non-coding RNA; Ovarian cancer; VEGFA.
© 2023. The Author(s) under exclusive licence to The Genetics Society of Korea.
Similar articles
-
A novel cancer-associated lncRNA, LINC01123, participates in tumor progression, metabolism, immune escape, and resistance.Front Immunol. 2025 Apr 4;16:1480447. doi: 10.3389/fimmu.2025.1480447. eCollection 2025. Front Immunol. 2025. PMID: 40255398 Free PMC article. Review.
-
STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.Cell Cycle. 2020 Jun;19(12):1502-1516. doi: 10.1080/15384101.2020.1757936. Epub 2020 May 13. Cell Cycle. 2020. Retraction in: Cell Cycle. 2023 May;22(9):1158. doi: 10.1080/15384101.2023.2188826. PMID: 32401659 Free PMC article. Retracted.
-
LINC01123 facilitates proliferation, invasion and chemoresistance of colon cancer cells.Biosci Rep. 2020 Aug 28;40(8):BSR20194062. doi: 10.1042/BSR20194062. Biosci Rep. 2020. PMID: 32700743 Free PMC article.
-
LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR-516b-5p/Gli1 axis.Cancer Sci. 2021 Jun;112(6):2260-2271. doi: 10.1111/cas.14913. Epub 2021 May 7. Cancer Sci. 2021. PMID: 33837611 Free PMC article.
-
LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.Cell Biochem Funct. 2020 Dec;38(8):1089-1099. doi: 10.1002/cbf.3565. Epub 2020 Jul 7. Cell Biochem Funct. 2020. PMID: 32638404
Cited by
-
Latest Update on lncRNA in Epithelial Ovarian Cancer-A Scoping Review.Cells. 2025 Apr 7;14(7):555. doi: 10.3390/cells14070555. Cells. 2025. PMID: 40214508 Free PMC article.
-
RNA Sequencing Reveals the Long Non-Coding RNA Signature in Psoriasis Keratinocytes and Identifies CYDAER as a Long Non-Coding RNA Regulating Epidermal Differentiation.Exp Dermatol. 2025 Feb;34(2):e70054. doi: 10.1111/exd.70054. Exp Dermatol. 2025. PMID: 39953783 Free PMC article.
-
LncRNA LINC01123-mediated impaired fracture healing through miR-134-5p/XIAP axis.J Orthop Surg Res. 2025 Aug 22;20(1):790. doi: 10.1186/s13018-025-06167-3. J Orthop Surg Res. 2025. PMID: 40847361 Free PMC article.
-
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications.Cancers (Basel). 2025 Jan 30;17(3):472. doi: 10.3390/cancers17030472. Cancers (Basel). 2025. PMID: 39941838 Free PMC article. Review.
-
A novel cancer-associated lncRNA, LINC01123, participates in tumor progression, metabolism, immune escape, and resistance.Front Immunol. 2025 Apr 4;16:1480447. doi: 10.3389/fimmu.2025.1480447. eCollection 2025. Front Immunol. 2025. PMID: 40255398 Free PMC article. Review.
References
-
- Cao HL, Liu ZJ, Huang PL, Yue YL, Xi JN (2019) lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206. Eur Rev Med Pharmacol Sci 23:1012–1021 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical